Literature DB >> 16084718

How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men.

Denis E Corpet1, Fabrice Pierre.   

Abstract

Tumours in rodent and human colon share many histological and genetic features. To know if rodent models of colon carcinogenesis are good predictors of chemopreventive efficacy in humans, we conducted a meta-analysis of aspirin, beta-carotene, calcium, and wheat bran studies. Controlled intervention studies of adenoma recurrence in human volunteers were compared with chemoprevention studies of carcinogen-induced tumours in rats, and of polyps in Min (Apc(+/-)) mice: 6714 volunteers, 3911 rats and 458 mice were included in the meta-analyses. Difference between models was small since most global relative risks were between 0.76 and 1.00. A closer look showed that carcinogen-induced rat studies matched human trials for aspirin, calcium, carotene, and were compatible for wheat bran. Min mice results were compatible with human results for aspirin, but discordant for calcium and wheat bran (no carotene study). These few results suggest that rodent models roughly predict effect in humans, but the prediction is not accurate for all agents. Based on three cases only, the carcinogen-induced rat model seems better than the Min mouse model. However, rodent studies are useful to screen potential chemopreventive agents, and to study mechanisms of carcinogenesis and chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084718     DOI: 10.1016/j.ejca.2005.06.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  69 in total

1.  Translating animal research into clinical benefit.

Authors:  Daniel G Hackam
Journal:  BMJ       Date:  2007-01-27

2.  Context specific transcription factor prediction.

Authors:  Eric Yang; David Simcha; Richard R Almon; Debra C Dubois; William J Jusko; Ioannis P Androulakis
Journal:  Ann Biomed Eng       Date:  2007-03-22       Impact factor: 3.934

3.  Why animal studies are often poor predictors of human reactions to exposure.

Authors:  Michael B Bracken
Journal:  J R Soc Med       Date:  2009-03       Impact factor: 5.344

4.  Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice.

Authors:  Gerd Bobe; Kathleen G Barrett; Roycelynn A Mentor-Marcel; Umberto Saffiotti; Matthew R Young; Nancy H Colburn; Paul S Albert; Maurice R Bennink; Elaine Lanza
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

5.  Novel diet-related mouse model of colon cancer parallels human colon cancer.

Authors:  Anil R Prasad; Shilpa Prasad; Huy Nguyen; Alexander Facista; Cristy Lewis; Beryl Zaitlin; Harris Bernstein; Carol Bernstein
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

Review 6.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

Review 7.  Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays.

Authors:  Sundeep A Chandra; Michael W Nolan; David E Malarkey
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

Review 8.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

9.  Beef meat promotion of dimethylhydrazine-induced colorectal carcinogenesis biomarkers is suppressed by dietary calcium.

Authors:  Fabrice Pierre; Raphaëlle Santarelli; Sylviane Taché; Françoise Guéraud; Denis E Corpet
Journal:  Br J Nutr       Date:  2007-10-22       Impact factor: 3.718

10.  Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats.

Authors:  Angelo Pietro Femia; Cristina Luceri; Simona Toti; Augusto Giannini; Piero Dolara; Giovanna Caderni
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.